Site-specific intravascular administration of drugs: history of a method applicable in humans.

Demonstration and quantification of site-specific intracoronary administration of pharmacological compounds has been limited thus far to animal experimental models. Recently, a method applicable in humans has been developed. The aim of this study is to give an overview on the available methods to visualize and quantify intravascularly administered "labeled" drugs in animals and to describe the historical development of a method now applied in the clinical arena. The potential of this approach is briefly summarized.

[1]  P. Serruys,et al.  Site-specific intracoronary heparin delivery in humans after balloon angioplasty. A radioisotopic assessment of regional pharmacokinetics. , 1997, Circulation.

[2]  P. Serruys,et al.  Intracoronary heparin delivery in humans. Acute feasibility and long-term results. , 1995, Circulation.

[3]  P. Yock,et al.  Intramural delivery of agent via a novel drug-delivery sleeve. Histological and functional evaluation. , 1995, Circulation.

[4]  S. King,et al.  Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. , 1995, Circulation.

[5]  R. Wilensky,et al.  Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters. , 1995, American heart journal.

[6]  P. Serruys,et al.  772-2 Local Intracoronary Delivery of Heparin and of a Somatostatin Analogue (Octreotide) Following Angioplasty in Man: Evaluation of Efficacy of Delivery by Radio-Isotopic Technique , 1995 .

[7]  D. Waters,et al.  Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. , 1995, Circulation.

[8]  P. Serruys,et al.  Late effects of locally delivered mitomycin C on formation of neointima and on vasomotor response to acetylcholine , 1994, Coronary artery disease.

[9]  D. Waters,et al.  Decreased Platelet Deposition and Smooth Muscle Cell Proliferation After Intramural Heparin Delivery With Hydrogel‐Coated Balloons , 1994, Circulation.

[10]  D. Waters,et al.  Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. , 1994, Journal of the American College of Cardiology.

[11]  S. King,et al.  Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. , 1994, Journal of the American College of Cardiology.

[12]  J. Isner.  Vascular remodeling. Honey, I think I shrunk the artery. , 1994, Circulation.

[13]  V. Fuster,et al.  A new approach for local intravascular drug delivery. Iontophoretic balloon. , 1994, Circulation.

[14]  K. Kent,et al.  The Effect of Porous Infusion Balloon‐Delivered Angiopeptin on Myointimal Hyperplasia After Balloon Injury in the Rabbit , 1993, Circulation.

[15]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[16]  E. Topol,et al.  Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. , 1992, Journal of the American College of Cardiology.

[17]  P. Serruys,et al.  Methodological problems related to the quantitative assessment of stretch, elastic recoil, and balloon-artery ratio. , 1992, Catheterization and cardiovascular diagnosis.

[18]  H. Wolinsky,et al.  Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. , 1991, Journal of the American College of Cardiology.

[19]  R. V. Van Tassel,et al.  Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi. , 1990, The American journal of cardiology.

[20]  S. Thung,et al.  Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. , 1990, Journal of the American College of Cardiology.

[21]  S. Thung,et al.  Local Introduction of Drugs into the Arterial Wall: A Percutaneous Catheter Technique , 1989 .

[22]  E. Nabel,et al.  Recombinant gene expression in vivo within endothelial cells of the arterial wall. , 1989, Science.

[23]  M. Kern,et al.  Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus. , 1988, The American journal of cardiology.

[24]  P W Serruys,et al.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. , 1988, Circulation.

[25]  M. Nobuyoshi,et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. , 1988, Journal of the American College of Cardiology.

[26]  B. Goldman,et al.  Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase. A new catheter approach. , 1987, Atherosclerosis.

[27]  N. Ratliff,et al.  Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. , 1985, Journal of the American College of Cardiology.

[28]  D. Holmes,et al.  Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. , 1985, Journal of the American College of Cardiology.

[29]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[30]  M. Reidy,et al.  Mechanisms of stenosis after arterial injury. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[31]  J. Reiber,et al.  The effect of intracoronary thrombolysis with streptokinase on myocardial thallium distribution and left ventricular function assessed by blood-pool scintigraphy. , 1982, European heart journal.

[32]  J. Willerson,et al.  Technetium-labeled heparin: preliminary report of a new radiopharmaceutical with potential for imaging damaged coronary arteries and myocardium. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.